iPhone Duo, Apple's foldable phone

iPhone Duo, Apple’s foldable phone

For some time now, Apple presentations have had few secrets left to reveal before they begin. Apple’s first foldable phone, the iPhone Duo, is already an announced reality. A device with a high price that arrives as the first emblem of the company’s new CEO, John Ternus, who on September 1st took over from Tim Cook, the man who has led the company for the past 15 years, since the retirement and passing of co-founder Steve Jobs. He even uttered the three words that characterized his most iconic presentations: “One more thing.”

Read More
The United States Treasury announces a one-dollar coin featuring Trump's face

The United States Treasury announces a one-dollar coin featuring Trump’s face

The United States Mint has already begun producing a new one-dollar coin in gold color featuring the ubiquitous face of President Donald Trump. This was announced by Treasury Secretary Scott Bessent through a post on the social network X, in which he explained that the coin commemorates the 250th anniversary of the country’s independence. “With the image of President Trump, it celebrates the strength of American values and the promise of a nation dedicated to preserving freedom for all,” Bessent added.

Read More
High taxation in Spain hinders households from investing their savings

High taxation in Spain hinders households from investing their savings

The higher taxation borne by investments in Spain compared to other comparable countries penalizes and hinders households from investing their savings. The effective rate borne on various products analyzed – stocks, deposits, funds… – rises to 22.3%, eight points higher than the 14.4% of the European Union, according to a report by the Institute of Economic Studies (IEE) and the Spanish Association of Financial Advisors and Planners (EFPA).

Read More
AstraZeneca and Bristol Myers Squibb are studying a $400 billion merger

AstraZeneca and Bristol Myers Squibb are studying a $400 billion merger

The British pharmaceutical company AstraZeneca is in talks to merge with its American rival Bristol Myers Squibb (BMS), in a deal that would create one of the largest pharmaceutical groups in the world, valued at nearly $400 billion (around €347 billion). According to the Financial Times on Monday, these two companies have been in contact about a possible merger over the past few months. These negotiations could culminate in an agreement in the near future, but they could also be delayed or fail, sources cited by the British newspaper indicate.

Read More